Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q1 2015 (← Previous) (Next →)
Filing Date: May 15, 2015
Total Value ($000): $260,578 (98.8% shares, 1.2% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | 4,211,399 | $45,820 | 17.6% | $7.51 | +17.4% | Common | 03152W109 |
| — | LION BIOTECHNOLOGIES INC | 2,149,907 | $26,035 | 10.0% | $12.11 | — | Common | 53619R102 |
| SRNE | SORRENTO THERAPEUTICS INC | 2,214,043 | $25,594 | 9.8% | $8.90 | +30.0% | Common | 83587F202 |
| — | CELGENE CORP. | 148,800 | $17,154 | 6.6% | $115.28 | — | Common | 151020904 |
| — | PERNIX THERAPEUTICS HOLDINGS | 1,395,167 | $14,914 | 5.7% | $9.63 | — | Common | 71426V108 |
| — | BELLICUM PHARMACEUTICALS INC | 475,015 | $11,006 | 4.2% | $23.11 | — | Common | 079481107 |
| — | AGENUS - INC | 2,047,971 | $10,506 | 4.0% | $3.97 | — | Common | 00847G705 |
| EBS | EMERGENT BIOSOLUTIONS INC | 330,635 | $9,509 | 3.6% | $23.83 | +20.3% | Common | 29089Q105 |
| — | MIRATI THERAPEUTICS INC. | 320,867 | $9,408 | 3.6% | $29.32 | — | Common | 60468T105 |
| — | LA JOLLA PHARMACEUTICAL CO. | 461,499 | $8,445 | 3.2% | $18.38 | — | Common | 503459604 |
| — | TARO PHARMACEUTICAL INDUS | 53,800 | $7,587 | 2.9% | $148.19 | — | Shares | M8737E108 |
| — | ONCOTHYREON INC | 4,491,636 | $7,321 | 2.8% | $1.81 | — | Common | 682324108 |
| — | RECEPTOS INC | 44,000 | $7,255 | 2.8% | $122.51 | — | Common | 756207106 |
| — | STEMLINE THERAPEUTICS - INC | 475,000 | $6,873 | 2.6% | $14.47 | — | Common | 85858C107 |
| — | IGI LABORATORIES INC | 720,908 | $5,883 | 2.3% | $8.57 | — | Common | 449575109 |
| QURE | UNIQURE N V | 226,456 | $5,507 | 2.1% | $21.81 | 0.0% | Common | N90064101 |
| — | TONIX PHARMACEUTICALS HLDG | 755,300 | $4,773 | 1.8% | $6.32 | — | Common | 890260201 |
| VCEL | VERICEL CORP. | 1,058,820 | $3,918 | 1.5% | $2.85 | +19.7% | Common | 92346J108 |
| — | FLAMEL TECHNOLOGIES | 215,705 | $3,878 | 1.5% | $17.13 | — | Sponsored ADR | 338488109 |
| SGMO | SANGAMO BIOSCIENCES INC | 244,199 | $3,829 | 1.5% | $15.47 | 0.0% | Common | 800677106 |
| — | TRILLIUM THERAPEUTICS INC | 160,697 | $3,234 | 1.2% | $20.12 | — | Common | 89620X506 |
| — | EXELIXIS INC EXEL 20190815 4.250000% | 4,250,000 | $3,234 | 1.2% | $0.56 | — | Notes | 30161QAC8 |
| — | CHEMOCENTRYX - INC | 323,607 | $2,443 | 0.9% | $7.55 | — | Common | 16383L106 |
| — | THERAPEUTICS MD INC | 392,000 | $2,372 | 0.9% | $6.05 | — | Common | 88338N107 |
| — | CORONADO BIOSCIENCES INC | 600,000 | $2,310 | 0.9% | $3.85 | — | Common | 21976U109 |
| — | TROVAGENE INC | 323,728 | $2,205 | 0.8% | $6.81 | — | Common | 897238309 |
| — | IGNYTA INC. | 200,772 | $1,998 | 0.8% | $6.85 | — | Common | 451731103 |
| — | INNOCOLL AG | 225,000 | $1,689 | 0.6% | $5.93 | — | Sponsored ADR | 45780Q103 |
| — | HEAT BIOLOGICS INC | 260,000 | $1,654 | 0.6% | $6.36 | — | Common | 42237K102 |
| — | BIOLASE INC | 690,000 | $1,394 | 0.5% | $2.63 | — | Common | 090911108 |
| — | TARGACEPT INC | 466,297 | $1,385 | 0.5% | $2.97 | — | Common | 87611R306 |
| CLLS | CELLECTIS | 30,000 | $1,037 | 0.4% | $34.57 | — | Sponsored ADS | 15117K103 |
| — | ALIMERA SCIENCES INC | 81,372 | $408 | 0.2% | $5.02 | — | Common | 016259103 |